Breadcrumb Navigation:

Home > Research > Research News > Research Call Archive > MS Treatments on the Horizon, May 2009

MS Treatments on the Horizon, May 2009

Listen to the Presentation (32 minutes)
Listen to the Questions and Answers (33 minutes)

 

 

Richard A. Rudick, M.D.

Dr. Rudick is Professor of Medicine and Chair of Neurology at the Cleveland Clinic.  He is also Director of the Cleveland Clinic’s Mellen Center for Multiple Sclerosis Treatment and Research and Vice Chairman of Research and Development in the Neurological Institute.

Dr. Patricia O'Looney

As Vice President of Biomedical Research at the National Multiple Sclerosis Society, Dr. O'Looney directs and oversees the administration of the Society’s biomedical research funding programs. Dr. O'Looney holds a bachelor's degree in Molecular Biology from Regis College, Weston, MA, and is a graduate of The George Washington University Medical School in Washington, D.C.